Thus, although different mechanism(s) for FGFRs are reported, a therapeutic scheme combining BET inhibitors and FGFR inhibition by AZD4547 treatment may be beneficial also against ovarian cancer. The gene discussed is DNER; the disease is ovarian cancer.